(Q43756689)

26 November 2017

title

Design of oxytocin antagonists, which are more selective than atosiban (English)

1 reference

26 November 2017

1 reference

Manning M

1

1 reference

26 November 2017

Stoev S

2

1 reference

26 November 2017

Cheng LL

3

1 reference

26 November 2017

Wo NC

4

1 reference

26 November 2017

Chan WY

5

1 reference

26 November 2017

language of work or name

1 reference

1 September 2001

1 reference

Journal of Peptide Science

26 November 2017

published in

1 reference

26 November 2017

volume

7

1 reference

26 November 2017

issue

9

1 reference

26 November 2017

page(s)

449-465

1 reference

The contribution of low birth weight to infant mortality and childhood morbidity

26 November 2017

cites work

1 reference

The continuing challenge of preterm delivery

21 January 2018

1 reference

Preterm birth prevention: where are we?

21 January 2018

1 reference

Stopping premature births before it's too late

21 January 2018

1 reference

21 January 2018

1 reference

Oxytocin Receptors: Triggers for Parturition and Lactation?

21 January 2018

1 reference

Oxytocin Receptors and Human Parturition: A Dual Role for Oxytocin in the Initiation of Labor

21 January 2018

1 reference

Oxytocin gene expression in rat uterus

21 January 2018

1 reference

Some pharmacological properties of a synthetic oxytocin analogue [1-N-carbamoyl-hemicystine-2-O-methyltyrosine]-oxytocin (carbamoyl-methyloxytocin), an antagonist to the neurohypophysial hormones

21 January 2018

1 reference

Synthetic antagonists of in vivo responses by the rat uterus to oxytocin

21 January 2018

1 reference

Effects of applied load and particle size on the plastoelasticity and tablet strength of some directly compressible powders

21 January 2018

1 reference

125I-labelled d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH2(9)]OVT: a selective oxytocin receptor ligand

21 January 2018

1 reference

Improvement in potency of an oxytocin antagonist after systematic substitutions with L-tryptophan

21 January 2018

1 reference

Systematic substitution of an oxytocin antagonist with D-amino acids: unexpected high antagonistic potency of the D-Cys6-substituted analogue

21 January 2018

1 reference

21 January 2018

1 reference

1-(1-[4-[(N-acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]piperidin-4- yl)-4H-3,1-benzoxazin-2(1H)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist

21 January 2018

1 reference

Design, synthesis and some uses of receptor-specific agonists and antagonists of vasopressin and oxytocin

21 January 2018

1 reference

Small molecule ligands for oxytocin and vasopressin receptors

21 January 2018

1 reference

The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human.

21 January 2018

1 reference

Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Atosiban Study Group.

21 January 2018

1 reference

Treatment of preterm labor with the oxytocin antagonist atosiban

21 January 2018

1 reference

An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue

21 January 2018

1 reference

Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study

21 January 2018

1 reference

Molecular pharmacology of V1a vasopressin receptors.

21 January 2018

1 reference

Structural bases of vasopressin/oxytocin receptor function

21 January 2018

1 reference

Pharmacologic characterization of the oxytocin receptor in human uterine smooth muscle cells

21 January 2018

1 reference

Discovery and design of novel and selective vasopressin and oxytocin agonists and antagonists: the role of bioassays

21 January 2018

1 reference

Solid phase synthesis of (1-deamino,4-valine)-8-D-arginine-vasopressin (DVDAVP), a highly potent and specific antidiuretic agent possessing protracted effects

21 January 2018

1 reference

Eine neue Methode zur Synthese von Peptiden: Aktivierung der Carboxylgruppe mit Dicyclohexylcarbodiimid unter Zusatz von 1‐Hydroxy‐benzotriazolen

21 January 2018

1 reference

Potent V2/V1a vasopressin antagonists with C-terminal ethylenediamine-linked retro-amino acids

21 January 2018

1 reference

Solid-phase synthesis and pressor potency of [1-deamino-9-ethylenediamine]-lysine-vasopressin

21 January 2018

1 reference

The Synthesis of Oxytocin1

21 January 2018

1 reference

pA, a new scale for the measurement of drug antagonism

21 January 2018

1 reference

(1-Beta-mercapto-beta,beta-diethylpropionic acid)-8-lysine-vasopressin, a potent inhibitor of 8-lysine-vasopressin and of oxytocin

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PSC.339

1 reference

release_cgxqvvkpnngk3pyfy3dv2edbae

26 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cgxqvvkpnngk3pyfy3dv2edbae

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference